CYBERMED LIFE - ORGANIC  & NATURAL LIVING

Dietary Modification - Glutamic and Aspartic Acid Reduced (G.A.R.D)

The effect of dietary glutamate on fibromyalgia and irritable bowel symptoms📎

Written by CYBERMED LIFE NEWS
Attachments:
Download this file (The effect of dietary glutamate on fibromyalgia and irritable bowel symptoms..pdf)The effect of dietary glutamate on fibromyalgia and irritable bowel symptoms..pdf[The effect of dietary glutamate on fibromyalgia and irritable bowel symptoms.]830 kB
facebook Share on Facebook
Abstract Title:

The effect of dietary glutamate on fibromyalgia and irritable bowel symptoms.

Abstract Source:

Clin Exp Rheumatol. 2012 Jul 4. Epub 2012 Jul 4. PMID: 22766026

Abstract Author(s):

Kathleen F Holton, Douglas L Taren, Cynthia A Thomson, Robert M Bennett, Kim D Jones

Article Affiliation:
Abstract:

OBJECTIVES: To examine the effects of a challenge with monosodium glutamate (MSG) as compared to placebo on the symptoms of fibromyalgia (FM), in participants who initially experienced>30% remission of symptoms on an excitotoxin elimination diet.

METHODS: Fifty-seven FM patients who also had irritable bowel syndrome (IBS) were placed on a 4-week diet that excluded dietary additive excitotoxins including MSG and aspartame. Thirty-seven people completed the diet and 84% of those reported that>30% of their symptoms resolved, thus making them eligible to proceed to challenges. Subjects who improved on the diet were then randomised to a 2-week double-blind placebo-controlled crossover challenge with MSG or placebo for 3 consecutive days each week. The primary outcome measure was total symptom score. Secondary outcome measures included visual analogue pain scales (VAS for FM and IBS), an IBS Quality of Life Questionnaire (IBS QOL) and the Fibromyalgia Impact Questionnaire-Revised (FIQR). Repeated measures ANOVA was used to analyse crossover challenge results.

RESULTS: The MSG challenge, as compared to placebo, resulted in a significant return of symptoms (total symptom score, p<0.02); a worsening of fibromyalgia severity as determined by the FIQR (p<0.03); decreased quality of life in regards to IBS symptoms (IBS QOL, p<0.05); and a non-significant trend toward worsening FM pain based on visual analogue scale (VAS, p<0.07).

CONCLUSIONS: These findings suggest that dietary glutamate may be contributing to FM symptoms in some patients. Future research on the role of dietary excitotoxins in FM is warranted.


We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.